SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Calypte Biomedical Corporation (CALY)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GemSeeker who wrote (161)10/15/1997 12:59:00 PM
From: Cindy Powell   of 381
 
Hello Gemseeker,

I agree with your comments regarding the low volume drift that is typical of story stocks in between news releases. If investors have been playing their cards right, they could have been in and out of this stock several times for some pretty pennies. We might be ready for a steady escalation now, though. The volatility that often accompanies the pre-FDA stage may be over with, and I think that once CALY starts attracting the serious attention of fund managers she will deliver some very pleasant surprises for investors. The FDA approval news has yet to be fully digested and appreciated by industry analysts and fund managers. I agree that this baby is severely underpriced.

Pleasant Day All,

Cindy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News